We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
CALL
eBay
EBAY
$47.9B
| $37.9M | 0.05% |
+435,000
| New | +$37.7M |
|
427
CALL
Pfizer
PFE
$154B
| $37.9M | 0.05% |
1,520,100
-430,600
| -22% | -$10.9M |
|
428
Service Corp International
SCI
$11.4B
| $37.8M | 0.05% |
484,616
+237,560
| +96% | +$19M |
|
429
CALL
Micron Technology
MU
$972B
| $37.5M | 0.05% |
131,400
+30,600
| +30% | +$7.02M |
|
430
PUT
iShares China Large-Cap ETF
FXI
$4.35B
| $37.4M | 0.05% |
976,800
+664,200
| +212% | +$26.4M |
|
431
BellRing Brands
BRBR
$1.32B
| $36.8M | 0.05% |
1,377,098
+1,160,625
| +536% | +$36M |
|
|
JAMF
432
DELISTED
Jamf
JAMF
| $36.8M | 0.05% |
2,828,701
+2,066,709
| +271% | +$25.1M |
|
|
SOLS
433
Solstice Advanced Materials
SOLS
$9.58B
| $36.7M | 0.05% |
+755,738
| New | +$35.6M |
|
434
Blackrock
BLK
$175B
| $36.5M | 0.05% |
34,135
+33,369
| +4,356% | +$36.5M |
|
435
Axalta
AXTA
$8.01B
| $36.5M | 0.05% |
1,129,965
-66,086
| -6% | -$1.94M |
|
436
PUT
Booking.com
BKNG
$160B
| $36.4M | 0.05% |
170,000
+107,500
| +172% | +$22.1M |
|
|
CTLP
437
PUT
DELISTED
Cantaloupe
CTLP
| $36.4M | 0.05% |
3,425,900
+1,299,600
| +61% | +$13.8M |
|
438
Alibaba
BABA
$317B
| $36.4M | 0.05% |
248,023
-202,451
| -45% | -$33M |
|
439
Sabra Healthcare REIT
SBRA
$5.28B
| $36.3M | 0.05% |
1,916,255
+1,691,792
| +754% | +$31.4M |
|
440
Genius Sports
GENI
$2.1B
| $36.2M | 0.05% |
3,289,270
+2,917,830
| +786% | +$31.8M |
|
441
PUT
Marathon Digital Holdings
MARA
$3.69B
| $36.2M | 0.05% |
4,031,100
-1,367,500
| -25% | -$20.2M |
|
442
PUT
Abbott
ABT
$188B
| $36.2M | 0.05% |
288,800
+209,800
| +266% | +$26.7M |
|
|
TERN
443
DELISTED
Terns Pharmaceuticals
TERN
| $36M | 0.05% |
+891,903
| New | +$20.6M |
|
444
Lear
LEA
$8.05B
| $35.9M | 0.05% |
+313,506
| New | +$33.5M |
|
445
ScottsMiracle-Gro
SMG
$3.63B
| $35.8M | 0.05% |
613,693
+172,356
| +39% | +$9.67M |
|
446
CBRE Group
CBRE
$41.7B
| $35.6M | 0.05% |
221,413
-310,271
| -58% | -$48.8M |
|
447
STAAR Surgical
STAA
$1.25B
| $35.6M | 0.05% |
1,541,160
-272,348
| -15% | -$7.02M |
|
448
Wintrust Financial
WTFC
$10.7B
| $35.6M | 0.05% |
254,329
+211,338
| +492% | +$28.1M |
|
449
Solventum
SOLV
$14.5B
| $35.5M | 0.05% |
448,181
-132,541
| -23% | -$10.2M |
|
450
PUT
Bloom Energy
BE
$62B
| $35.4M | 0.05% |
407,800
+149,500
| +58% | +$15.7M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.